NCT05238922 2026-02-10Study of INCB123667 in Subjects With Advanced Solid TumorsIncyte CorporationPhase 1 Recruiting604 enrolled
NCT04774952 2025-04-15Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid TumorsRevolution Medicines, Inc.Phase 1 Completed58 enrolled